This invention belongs to the field of
immunoassay detection and discloses a ZrMPNs-NlucmAb bioluminescent
signal probe and its application. The probe consists of a ZrMPNs
signal carrier and its electrostatically adsorbed bioluminescent
enzyme-labeled
monoclonal antibody NlucmAb. This invention utilizes the ZrMPNs-NlucmAb probe to construct a bioluminescent test strip (BLFA), which requires no external
light source and achieves a high luminescent
signal in a furazine (FZ)-Nluc
system, thus enabling sensitive detection of OTA. The limit of detection (LOD) of BLFA is 0.02 ng / mL, which is 9 times more sensitive than traditional gold
nanoparticle-based LFAs. The cross-reactivity rates of this BLFA to OTB and OTC are 122.2% and 111.1%, respectively, and it does not recognize other common
fungal toxins, exhibiting good specificity. Its application in the detection of OTA in cereals shows great promise.